NEW YORK – With a pair of recent high-profile publications validating one of its main proteomic assays, multi-omics firm Complete Omics is now looking to raise new funding and expand its product menu.
NEW YORK – With a pair of recent high-profile publications validating one of its main proteomic assays, multi-omics firm Complete Omics is now looking to raise new funding and expand its product menu.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.